Revenue CAGR:10.28%(TTM)
Based on reported financial statement history.
Over longer horizons, Revenue CAGR averages 11.31% over 3 years and 12.37% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Revenue CAGR measures how the company's top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
RMD Revenue CAGR Chart
ResMed Inc. (RMD)
RMD Quarterly Revenue Growth (YoY)
Revenue growth vs the same quarter one year earlier, last 20 quarters.
RMD Revenue CAGR History
| Year | Start Revenue | End Revenue | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $4.69B | $5.15B | +$461.03M | +9.84% | +9.84% |
| 2024 | $4.22B | $4.69B | +$462.30M | +10.95% | +10.95% |
| 2023 | $3.58B | $4.22B | +$644.87M | +18.02% | +18.02% |
| 2022 | $3.20B | $3.58B | +$381.30M | +11.93% | +11.93% |
| 2021 | $2.96B | $3.20B | +$239.81M | +8.11% | +8.11% |
| 2020 | $2.61B | $2.96B | +$350.44M | +13.44% | +13.44% |
| 2019 | $2.34B | $2.61B | +$266.38M | +11.38% | +11.38% |
| 2018 | $2.07B | $2.34B | +$273.46M | +13.23% | +13.23% |
| 2017 | $1.84B | $2.07B | +$228.02M | +12.40% | +12.40% |
| 2016 | $1.68B | $1.84B | +$159.80M | +9.52% | +9.52% |
| 2015 | $1.55B | $1.68B | +$123.94M | +7.97% | +7.97% |
| 2014 | $1.51B | $1.55B | +$40.52M | +2.68% | +2.68% |
| 2013 | $1.37B | $1.51B | +$145.94M | +10.66% | +10.66% |
| 2012 | $1.24B | $1.37B | +$125.37M | +10.08% | +10.08% |
| 2011 | $1.09B | $1.24B | +$150.79M | +13.80% | +13.80% |
| 2010 | $920.74M | $1.09B | +$171.62M | +18.64% | +18.64% |
| 2009 | $835.40M | $920.74M | +$85.34M | +10.22% | +10.22% |
| 2008 | $716.33M | $835.40M | +$119.06M | +16.62% | +16.62% |
| 2007 | $607.00M | $716.33M | +$109.34M | +18.01% | +18.01% |
| 2006 | $425.50M | $607.00M | +$181.49M | +42.65% | +42.65% |
| 2005 | $339.34M | $425.50M | +$86.17M | +25.39% | +25.39% |
| 2004 | $273.57M | $339.34M | +$65.77M | +24.04% | +24.04% |
| 2003 | $204.08M | $273.57M | +$69.49M | +34.05% | +34.05% |
| 2002 | $155.16M | $204.08M | +$48.92M | +31.53% | +31.53% |
| 2001 | $115.61M | $155.16M | +$39.54M | +34.20% | +34.20% |
| 2000 | $88.60M | $115.61M | +$27.02M | +30.49% | +30.49% |
| 1999 | $66.50M | $88.60M | +$22.10M | +33.23% | +33.23% |
| 1998 | $49.20M | $66.50M | +$17.30M | +35.16% | +35.16% |
| 1997 | $34.60M | $49.20M | +$14.60M | +42.20% | +42.20% |
Quarterly Revenue: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q3 2026 | $1.43B | +0.6% | +10.8% |
| Q2 2025 | $1.42B | +6.5% | +11.0% |
| Q1 2025 | $1.34B | -0.9% | +9.1% |
| Q4 2025 | $1.35B | +4.4% | +10.2% |
| Q3 2025 | $1.29B | +0.8% | +7.9% |
| Q2 2024 | $1.28B | +4.7% | +10.3% |
| Q1 2024 | $1.22B | +0.1% | +11.1% |
| Q4 2024 | $1.22B | +2.2% | +9.0% |
| Q3 2024 | $1.20B | +2.9% | +7.2% |
| Q2 2023 | $1.16B | +5.5% | +12.5% |
| Q1 2023 | $1.10B | -1.8% | +16.0% |
| Q4 2023 | $1.12B | +0.5% | +22.7% |
| Q3 2023 | $1.12B | +8.0% | +29.2% |
| Q2 2022 | $1.03B | +8.8% | +15.5% |
| Q1 2022 | $950.29M | +3.9% | +5.1% |
| Q4 2022 | $914.74M | +5.8% | +4.4% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell